Skip to main content

Advertisement

Cell therapy for relapsed cancer patients | Video

02:57 Min

Singapore has successfully treated its first patient using what is known as chimeric antigen receptor T-cell, or CAR-T therapy. But as Cheryl Goh reports, the treatment comes with a hefty price tag.

Singapore has successfully treated its first patient using what is known as chimeric antigen receptor T-cell, or CAR-T therapy. But as Cheryl Goh reports, the treatment comes with a hefty price tag.

Advertisement

You May Also Like

Advertisement